Search results
Showing 1 to 2 of 2 results for atidarsagene autotemcel
Atidarsagene autotemcel for treating metachromatic leukodystrophy (HST18)
Evidence-based recommendations on atidarsagene autotemcel (Libmeldy) for treating metachromatic leukodystrophy in children.
Children with a rare, fatal, genetic disorder will be able to benefit from a new one-off treatment under new NICE guidance.